Trial Profile
Autologous Engineered Skin Substitutes for Closure of Burn Wounds
Status:
Discontinued
Phase of Trial:
Phase II/III
Latest Information Update: 24 Apr 2019
Price :
$35
*
At a glance
- Drugs Human skin replacement Amarantus Bioscience (Primary)
- Indications Burns; Nevus; Scars
- Focus Therapeutic Use
- 16 Jun 2016 New trial record
- 16 Jun 2016 New trial record